Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. - Pivonello R; Petersenn S; Newell-Price J; Findling JW; Gu F; Maldonado M; Trovato A; Hughes G; Salgado LR; Lacroix A; Schopohl J; Biller BM (Clinical endocrinology, 2014)